Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Advances in OncologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: Phase III trial NRG oncology CC001.J Clin Oncol. 2020; 38: 1019-1029
- Endocrine deficiency as a function of radiation dose to the hypothalamus and pituitary in pediatric and young adult patients with brain tumors.J Clin Oncol. 2018; 36: 2854-2862
- Microstructural injury to corpus callosum and intrahemispheric white matter tracts correlate with attention and processing speed decline after brain radiation.Int J Radiat Oncol Biol Phys. 2021; 110: 337-347
- Advances in radio-oncology. From precision radiotherapy with photons to ion therapy with protons and carbon ions.Chirurg. 2006; 77: 1126-1132
- Biological considerations when comparing proton therapy with photon therapy.Semin Radiat Oncol. 2013; 23: 77-87
- CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015.Neuro Oncol. 2018; 20: iv1-iv86
- Prognostic factors and nomogram predicting survival in diffuse astrocytoma.J Neurosci Rural Pract. 2020; 11: 135-143
- Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial.Lancet. 2005; 366 ([Erratum appears in Lancet 2006;367(9525):1818]): 985-990
- Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: Results of a prospective clinical trial.J Neurosurg. 2008; 109: 835-841
- Radiation plus Procarbazine, CCNU, and vincristine in low-grade Glioma.N Engl J Med. 2016; 374: 1344-1355
- A comparison of critical structure dose and toxicity risks in patients with low grade gliomas treated with IMRT versus proton radiation therapy.Technol Cancer Res Treat. 2013; 12: 1-9
- Intensity-modulated proton therapy decreases dose to organs at risk in low-grade glioma patients: results of a multicentric in silico ROCOCO trial.Acta Oncol. 2019; 58: 57-65
- First experiences in treatment of low-grade glioma grade I and II with proton therapy.Radiat Oncol. 2012; 7: 189
- Long-term outcomes and late adverse effects of a prospective study on proton radiotherapy for patients with low-grade glioma.Radiother Oncol. 2019; 137: 95-101
- Molecular markers in low-grade glioma-toward tumor reclassification.Semin Radiat Oncol. 2015; 25: 155-163
- Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors.N Engl J Med. 2015; 372: 2499-3250
- Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.Lancet Oncol. 2016; 17: 1521-2153
- Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.J Clin Oncol. 2013; 31: 337-343
- Cognitive outcomes in patients with low-grade glioma.Neuro Oncol. 2021; 23: 709-710
- Short-course radiation plus temozolomide in elderly patients with glioblastoma.N Engl J Med. 2017; 376: 1027-1037
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.Lancet Oncol. 2009; 10: 459-466
- Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial.J Clin Oncol. 2013; 31: 4085-4091
- A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma.Neuro Oncol. 2021; 23: 1337-1347
- Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial.J Neurosurg. 1999; 91: 251-260
- Hypofractionated radiotherapy for glioblastoma: strategy for poor-risk patients or hope for the future?.Br J Radiol. 2012; 85: e770-e781
- Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide.Clin Cancer Res. 2011; 17: 5473-5480
- Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons.Neuro Oncol. 2021; 23: 284-294
- Therapeutic options in recurrent glioblastoma--An update.Crit Rev Oncol Hematol. 2016; 99: 389-408
- Clinical outcomes in patients with recurrent glioblastoma treated with proton beam therapy reirradiation: analysis of the multi-institutional proton collaborative group registry.Adv Radiat Oncol. 2020; 5: 978-983
- Proton therapy re-irradiation preserves health-related quality of life in large recurrent glioblastoma.J Cancer Res Clin Oncol. 2020; 146: 1615-1622
- Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.J Neurosurg. 2018; 129 ([Erratum appears in J Neurosurg 2018;129(6):1650]): 35-47
- Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions.Int J Radiat Oncol Biol Phys. 2004; 60: 1314-1324
- Radiotherapy of small intracranial tumours with different advanced techniques using photon and proton beams: a treatment planning study.Radiother Oncol. 2003; 68: 1-14
- Lower doses to hippocampi and other brain structures for skull-base meningiomas with intensity modulated proton therapy compared to photon therapy.Radiother Oncol. 2020; 142: 147-153
- Optimizing radiotherapy of orbital and paraorbital tumors: intensity-modulated X-ray beams vs. intensity-modulated proton beams.Int J Radiat Oncol Biol Phys. 2000; 47: 1111-1119
- Projected second tumor risk and dose to neurocognitive structures after proton versus photon radiotherapy for benign meningioma.Int J Radiat Oncol Biol Phys. 2012; 83: e495-e500
- Incidence of second malignancies among patients treated with proton versus photon radiation.Int J Radiat Oncol Biol Phys. 2013; 87: 46-52
- Long-term outcomes of patients with unresectable benign meningioma treated with proton beam therapy.J Radiat Res. 2021; 62: 427-437
- Long-term clinical outcomes of pencil beam scanning proton therapy for benign and non-benign intracranial meningiomas.Int J Radiat Oncol Biol Phys. 2017; 99: 1190-1198
- Meningiomas: knowledge base, treatment outcomes, and uncertainties: a RANO review.J Neurosurg. 2015; 122: 4-23
- Clinical outcomes of recurrent intracranial meningiomas treated with proton beam reirradiation.Int J Part Ther. 2019; 5: 11-22
- Brain-specific relative biological effectiveness of protons based on long-term outcome of patients with nasopharyngeal carcinoma.Int J Radiat Oncol Biol Phys. 2021; 110: 984-992
- Relative survival of childhood and adult medulloblastomas and primitive neuroectodermal tumors (PNETs).Cancer. 2012; 118: 1313-1322
- Medulloblastoma: long-term results for patients treated with definitive radiation therapy during the computed tomography era.Int J Radiat Oncol Biol Phys. 1996; 36: 29-35
- Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study.Lancet Oncol. 2016; 17 ([Erratum appears in Lancet Oncol 2020;21(3):e132]): 287-298
- Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastoma.Int J Radiat Oncol Biol Phys. 2013; 86: 277-284
- Descriptive epidemiology of chordomas in the United States.J Neurooncol. 2020; 148: 173-178
- Characteristics and patterns of metastatic disease from chordoma.Sarcoma. 2015; 2015: 517657
- Chordomas: a review.Neurosurg Clin N Am. 2015; 26: 437-452
- Building a global consensus approach to chordoma: a position paper from the medical and patient community.Lancet Oncol. 2015; 16: e71-e83
- Skull base chordoma treated with proton therapy: a systematic review.Surg Neurol Int. 2019; 10: 96
- Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas.Int J Radiat Oncol Biol Phys. 2009; 74: 732-739
- The role of dose escalation and proton therapy in perioperative or definitive treatment of chondrosarcoma and chordoma: An analysis of the National Cancer Data Base.Cancer. 2019; 125: 642-651
- Vestibular Schwannoma.in: Møller A.R. Langguth B. De Ridder D. Textbook of tinnitus. Springer, 2011: 681-686
- A comprehensive analysis of hearing preservation after radiosurgery for vestibular schwannoma: Clinical article.J Neurosurg. 2010; 112: 851-859
- Modern management of vestibular schwannomas.Prog Neurol Surg. 2007; 20: 129-141
- Fractionated proton beam therapy for acoustic neuromas: tumor control and hearing preservation.Int J Part Ther. 2018; 4: 28-36
- Long-term results of stereotactic proton beam radiotherapy for acoustic neuromas.Radiother Oncol. 2009; 90: 208-212
- Long-term outcomes of fractionated stereotactic proton therapy for vestibular schwannoma: a case series.Int J Part Ther. 2018; 4: 37-46
- Clinical outcomes and toxicity of proton radiotherapy for vestibular schwannomas: a systematic review.J Radiat Oncol. 2019; 8: 357-368
- Gamma Knife radiosurgery for facial nerve schwannomas: a multicenter study.J Neurosurg. 2015; 123: 387-394
- Thyrotropin-secreting Pituitary Tumors Endocr Rev. 1996; 17: 610-638
- Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria.J Clin Endocrinol Metab. 2001; 86: 4072-4077
- Radiation therapy in the multimodal treatment approach of pituitary adenoma.Strahlenther Onkol. 2002; 178: 173-186
- Radiation therapy in the management of pituitary adenomas.J Clin Endocrinol Metab. 2011; 96: 1992-2003
- Radiotherapy of small intracranial tumours with different advanced techniques using photon and proton beams: A treatment planning study.Radiother Oncol. 2003; 68: 1-14
- Modeling intracranial second tumor risk and estimates of clinical toxicity with various radiation therapy techniques for patients with pituitary adenoma.Technol Cancer Res Treat. 2011; 10: 243-251
- Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas.Int J Radiat Oncol Biol Phys. 2012; 82: 643-652
- Proton-beam therapy of pituitary disease: bragg peak proton treatment for pituitary-related conditions.Proc R Soc Med. 1974; 67: 32-33
- Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas.J Clin Endocrinol Metab. 2008; 93: 393-399
- Proton stereotactic radiosurgery in management of persistent acromegaly.Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol. 2007; 13: 726-734
- Outcomes of proton therapy for patients with functional pituitary adenomas.Int J Radiat Oncol Biol Phys. 2014; 90: 532-539
- Fractionated proton beam irradiation of pituitary adenomas.Int J Radiat Oncol Biol Phys. 2006; 64: 425-434
- Management of recurrent and refractory Cushing’s disease with reoperation and/or proton beam radiosurgery.Clin Neurosurg. 2008; 55: 141-144
- Proton beam therapy in acromegaly.N Engl J Med. 1968; 278: 669-695
- Proton beam therapy.Br J Cancer. 2005; 93: 849-854
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
